Lazard Japanese Equity ETF (JPY US) stock market data APIs
39.4628
-0.01(-0%)
as of September 11, 2026
Try our APIs with
free plan!
Lazard Japanese Equity ETF Financial Data Overview
Price chart is built with
Anychart
Prev. Close
39.4628
Open
39.4523
High
39.4876
Low
39.4208
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Lazard Japanese Equity ETF data using free add-ons & libraries
End-of-day & Earnings data
Get Lazard Japanese Equity ETF Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Lazard Japanese Equity ETF News
New
’Sell America’ trade returns as Fed, yen risks mount
Investing.com - Barclays says the 'Sell America' narrative has re-emerged in rates and currency markets, but a full-fledged regime shift has not yet arrived. U.S. and global equities have continued gr...
Buy $5B-$10B worth of Japanese yen, Bessent's 'to do' list shows: Reuters
[State Department Holds Ministerial On The Resurgence Of Political Terrorism] Finn Gomez/Getty Images News A Reuters photograph taken during President Donald Trump's cabinet meeting held at Camp D...
Japanese Yen: Homeward investment shift could support recovery – MUFG
MUFG’s Derek Halpenny highlights that the Japanese Yen (JPY) remains near cyclical lows, but Government Pension Investment Fund (GPIF) and Japan Trusts flows already show a shift back toward JGBs.
FDA Approves AstraZeneca And Daiichi's Datroway For Treating Metastatic Breast Cancer
(RTTNews) - AstraZeneca PLC (AZN), a biopharmaceutical company, and Daiichi Sankyo Company Limited (4568.T), a healthcare company, on Friday announced the approval of Datroway in the treatment of meta...
Get Lazard Japanese Equity ETF fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
